Literature DB >> 2525027

Truncated forms of human complement factor H.

M Fontaine1, M J Demares, V Koistinen, A J Day, C Davrinche, R B Sim, J Ripoche.   

Abstract

By the use of Western-blot analyses with polyclonal anti-(Factor H) antibodies, two low-Mr protein species of Mr 41,000 and 37,000 under non-reducing conditions and 43,000 and 40,000 under reducing conditions are consistently detected together with the well-known 155,000-Mr Factor H in human plasma and serum. These two additional species are also found in plasma, urine and synovial fluids. The 41,000-Mr species but not the 37,00-Mr species is detected by a monoclonal anti-(Factor H) antibody directed at the N-terminal part of Factor H. The 37,000-Mr species but not the 41,000-Mr species is detected by a monoclonal anti-(Factor H) antibody directed at the C-terminal part of Factor H. The 41,000-Mr and 37,000-Mr species are different from the well-characterized 36,000-Mr N-terminal tryptic fragment of Factor H. They are likely to represent translational products of the short Factor H mRNA species of 1.8 kb and 1.2-1.5 kb occurring in human liver that we have recently described.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525027      PMCID: PMC1138455          DOI: 10.1042/bj2580927

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  The complete amino acid sequence of human complement factor H.

Authors:  J Ripoche; A J Day; T J Harris; R B Sim
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography.

Authors:  J Ripoche; A Al Salihi; J Rousseaux; M Fontaine
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

6.  Monoclonal antibodies against the complement control protein factor H (beta 1 H).

Authors:  E Sim; M S Palmer; M Puklavec; R B Sim
Journal:  Biosci Rep       Date:  1983-12       Impact factor: 3.840

7.  Purification and structural studies on the complement-system control protein beta 1H (Factor H).

Authors:  R B Sim; R G DiScipio
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

8.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Human genes for three complement components that regulate the activation of C3 are tightly linked.

Authors:  S Rodriguez de Cordoba; D M Lublin; P Rubinstein; J P Atkinson
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  16 in total

1.  Polymorphism and deficiency of human factor H-related proteins p39 and p37.

Authors:  E Feifel; W M Prodinger; M Mölgg; W Schwaeble; D Schönitzer; V Koistinen; R Misasi; M P Dierich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins.

Authors:  W M Prodinger; J Hellwage; M Spruth; M P Dierich; P F Zipfel
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

3.  Identification of human complement factor H as a chemotactic protein for monocytes.

Authors:  K Nabil; B Rihn; M C Jaurand; J M Vignaud; J Ripoche; Y Martinet; N Martinet
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

Authors:  T Sakari Jokiranta; Zhu-Zhu Cheng; Harald Seeberger; Mihály Jòzsi; Stefan Heinen; Marina Noris; Giuseppe Remuzzi; Rebecca Ormsby; David L Gordon; Seppo Meri; Jens Hellwage; Peter F Zipfel
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

5.  Prevalence of the 1.8 kb complement factor H mRNA in human lung.

Authors:  M J Demares; C Davrinche
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

6.  The yeast Candida albicans binds complement regulators factor H and FHL-1.

Authors:  T Meri; A Hartmann; D Lenk; R Eck; R Würzner; J Hellwage; S Meri; P F Zipfel
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 7.  The complement system in age-related macular degeneration.

Authors:  Angela Armento; Marius Ueffing; Simon J Clark
Journal:  Cell Mol Life Sci       Date:  2021-03-09       Impact factor: 9.261

8.  The outer membrane protease PgtE of Salmonella enterica interferes with the alternative complement pathway by cleaving factors B and H.

Authors:  Rauna Riva; Timo K Korhonen; Seppo Meri
Journal:  Front Microbiol       Date:  2015-02-06       Impact factor: 5.640

9.  A Personal Tribute to Robert B. Sim with Reflections on Our Work Together on Factor H.

Authors:  Anthony J Day
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

10.  Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.

Authors:  Simon J Clark; Christoph Q Schmidt; Anne M White; Svetlana Hakobyan; B Paul Morgan; Paul N Bishop
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.